相关实验视频

Updated: Jul 11, 2025

Studying Metabolic Brain Connectivity Using 2-Deoxy-2-[18F]Fluoro-D-Glucose Dynamic Positron Emission Tomography at the Single-subject Level

Studying Metabolic Brain Connectivity Using 2-Deoxy-2-[¹⁸F]Fluoro-D-Glucose Dynamic Positron Emission Tomography at the Single-subject Level

Published on: January 24, 2025

开发一种PET标记器,用于OGA,在活大脑中改善动力学

Brendon E Cook¹, Sangram Nag^2,3, Ryosuke Arakawa^2,3

¹Biogen, Cambridge, Massachusetts.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

|November 7, 2023

概括

研究人员开发了两种PET标记剂[11C]BIO-735和[11C]BIO-578,以准阿尔茨海默病研究中的O-GlcNAcase (OGA). 追踪器[11C]BIO-578显示出有前途的大脑动力学和选择性,使其适合人类研究.

科学领域:

神经科学是一个神经科学.
生物化学生物化学
放射化学放射化学是指辐射化学.

背景情况:

O-GlcNAcylation通过调节陶聚合来影响阿尔茨海默病中的陶病理.
O-GlcNAcase (OGA) 调节O-GlcNAcylation;开发OGA的PET追踪剂对于测试OGA抑制剂至关重要.
准OGA可能为阿尔茨海默病提供治疗策略.

研究的目的:

开发和评估O-GlcNAcase (OGA) 的新型正子发射断层扫描 (PET) 追踪器.
评估这些标记物在阿尔茨海默病研究中的临床前和潜在临床应用的适用性.
为了识别具有高亲和力和对OGA的选择性和有利的PET成像特性的化合物.

主要方法:

对小分子化合物的OGA抑制活性和PET标记物属性的选.
化合物的选择和分析,包括放射性和竞争结合测定.
在生体内对大鼠进行的药理动力学研究和在动物和非人类灵长类动物 (NHPs) 进行的PET成像研究,使用11C标记的痕迹剂.

主要成果:

两种PET标记物[11C]BIO-735和[11C]BIO-578在体外显示出对OGA的高度亲和力和选择性.
[11C]BIO-578表现出有利的大脑吸收和可逆的结合动力学,适合在动物和NHP中进行PET成像量化.
通过阻断用于已知OGA抑制剂thiamet G的研究,证实了标记物吸收的特异性.

结论:

开发的PET标记物,特别是[11C]BIO-578,是针对OGA的有效工具.
[11C]BIO-578显示出出色的脑动力学和特异性,支持其在人类研究中的进一步评估.
这些发现为对阿尔茨海默病的OGA向疗法的临床研究铺平了道路.

关键词:

这就是阿尔茨海默病的原因.在O-GlcNA案例中.这是OGAGA,OGAGA.在这里,PET是PET.

更多相关视频

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on: February 3, 2023

Multi-Tracer Studies of Brain Oxygen and Glucose Metabolism Using a Time-of-Flight Positron Emission Tomography-Computed Tomography Scanner

Multi-Tracer Studies of Brain Oxygen and Glucose Metabolism Using a Time-of-Flight Positron Emission Tomography-Computed Tomography Scanner

Published on: June 7, 2024

相关概念视频

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...